Glucose Monitoring in Treatment of Postprandial Hypoglycemia After Gastric Bypass Surgery

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorSykehuset i Vestfold HF

About this trial

The goal of this clinical trial is to learn if continuous glucose monitoring works to treat postprandial hypoglycaemia in patients who have undergone gastric bypass surgery. The main question it aims to answer is:

• Is continuous glucose monitoring superior to usual care for prevention of postprandial hypoglycaemia in patients with verified postprandial hypoglycaemia after gastric bypass surgery?

Researchers will compare continuous glucose monitoring to usual care to see if continuous glucose monitoring works to treat postprandial hypoglycaemia.

Participants will:

* Use a continuous glucose monitor for 6 weeks or use no continuous glucose monitor for 5 weeks and wear a blinded continuous glucose monitor for 1 week. * Visit the clinic 2-3 times and have 2-3 phone consultations. * Register symptoms of hypoglycaemia, answer questionnaires, undergo a 24-hour dietary recall interview conducted by a registered dietitian, measure weight and body composition and take blood samples.

Eligibility criteria

Qualifiers

Gastric bypass surgery at least 1 year ago

Age ≥18 years

Symptomatic postprandial hypoglycaemia; capillary glucose level <3.0 mmol/L 1-4 hours after meals

Disqualifiers

Not able to give informed consent

Reduced compliance due to severe mental and psychiatric conditions

Use of insulin or sulfonylureas

Use of systemic corticosteroids

Trial design

Treatments tested in this trial

  • Continuous glucose monitor (Dexcom® G7)

Treatment groups

100 Participants
are divided into 2 treatment groups

Sponsors and collaborators